Jeffrey S. Flier, M.D., receives Endocrine Society Award

June 26, 2003

CHEVY CHASE, MD - Jeffrey S. Flier, M.D., Chief Academic Officer of Beth Israel Deaconess Medical Center (BIDMC) and George C. Reisman Professor of Medicine at Harvard Medical School, received the 2003 Edwin B. Astwood Lecture Award from the Endocrine Society during the Society's 85th Annual Meeting in Philadelphia.

Presented annually for outstanding endocrinology research, the Edwin B. Astwood Lecture Award represents one of the most distinguished honors in the field of endocrinology.

A member of the Endocrine Division at BIDMC, Flier's 30 years of research in the fields of diabetes and obesity has led to a greater understanding of insulin and leptin resistance, and to obesity's role in causing the metabolic syndrome.

His work has demonstrated that the hormone leptin not only regulates appetite, but also serves as a regulator of the neuroendocrine axis for reproductive, thyroid and adrenal control.

Flier's recent work has found strong evidence that glucocorticoid reactivation in adipose tissue can produce a murine equivalent of the metabolic syndrome, characterized by visceral obesity, insulin-resistant diabetes, hyperlipidemia, and hypertension.

Flier received his medical degree from Mount Sinai School of Medicine, in 1972. An elected fellow of the American Academy of Arts and Sciences, Flier holds an honorary doctorate from the University of Athens. He has published more than 200 peer-reviewed papers in leading scientific journals.
-end-
Founded in 1916, the Endocrine Society is the world's oldest, largest and most active organization devoted to research on hormones and the clinical practice of endocrinology. Based in Chevy Chase, MD., the Society's membership consists of over 10,000 scientists, physicians, educators, nurses and students from more than 80 countries.

Beth Israel Deaconess Medical Center is a major patient care, teaching, and research affiliate of Harvard Medical School, ranking third in National Institutes of Health (NIH) funding among independent hospitals nationwide. The medical center is clinically affiliated with the Joslin Diabetes Center and is a founding member of the Dana-Farber/Harvard Cancer Center. BIDMC is the official hospital of the Boston Red Sox.

Beth Israel Deaconess Medical Center

Related Diabetes Articles from Brightsurf:

New diabetes medication reduced heart event risk in those with diabetes and kidney disease
Sotagliflozin - a type of medication known as an SGLT2 inhibitor primarily prescribed for Type 2 diabetes - reduces the risk of adverse cardiovascular events for patients with diabetes and kidney disease.

Diabetes drug boosts survival in patients with type 2 diabetes and COVID-19 pneumonia
Sitagliptin, a drug to lower blood sugar in type 2 diabetes, also improves survival in diabetic patients hospitalized with COVID-19, suggests a multicenter observational study in Italy.

Making sense of diabetes
Throughout her 38-year nursing career, Laurel Despins has progressed from a bedside nurse to a clinical nurse specialist and has worked in medical, surgical and cardiac intensive care units.

Helping teens with type 1 diabetes improve diabetes control with MyDiaText
Adolescence is a difficult period of development, made more complex for those with Type 1 diabetes mellitus (T1DM).

Diabetes-in-a-dish model uncovers new insights into the cause of type 2 diabetes
Researchers have developed a novel 'disease-in-a-dish' model to study the basic molecular factors that lead to the development of type 2 diabetes, uncovering the potential existence of major signaling defects both inside and outside of the classical insulin signaling cascade, and providing new perspectives on the mechanisms behind insulin resistance in type 2 diabetes and possibly opportunities for the development of novel therapeutics for the disease.

Tele-diabetes to manage new-onset diabetes during COVID-19 pandemic
Two new case studies highlight the use of tele-diabetes to manage new-onset type 1 diabetes in an adult and an infant during the COVID-19 pandemic.

Genetic profile may predict type 2 diabetes risk among women with gestational diabetes
Women who go on to develop type 2 diabetes after having gestational, or pregnancy-related, diabetes are more likely to have particular genetic profiles, suggests an analysis by researchers at the National Institutes of Health and other institutions.

Maternal gestational diabetes linked to diabetes in children
Children and youth of mothers who had gestational diabetes during pregnancy are at increased risk of diabetes themselves, according to new research published in CMAJ (Canadian Medical Association Journal).

Two diabetes medications don't slow progression of type 2 diabetes in youth
In youth with impaired glucose tolerance or recent-onset type 2 diabetes, neither initial treatment with long-acting insulin followed by the drug metformin, nor metformin alone preserved the body's ability to make insulin, according to results published online June 25 in Diabetes Care.

People with diabetes visit the dentist less frequently despite link between diabetes, oral health
Adults with diabetes are less likely to visit the dentist than people with prediabetes or without diabetes, finds a new study led by researchers at NYU Rory Meyers College of Nursing and East Carolina University's Brody School of Medicine.

Read More: Diabetes News and Diabetes Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.